Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 12208-12209 [06-2215]

Download as PDF 12208 Federal Register / Vol. 71, No. 46 / Thursday, March 9, 2006 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEAL AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Nutrient Restriction: Placental and Fetal Brain and Renal Outcomes and Mechanisms. Date: March 21, 2006. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gopal M. Bhatnagar, PhD, Scientific Review Administrator, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Bldg 5B01, Rockville, MD 20852. (301) 435–6889. bhatnagg@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. hsrobinson on PROD1PC70 with NOTICES (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: February 24, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2227 Filed 3–8–06; 8:45 am] 13:58 Mar 08, 2006 Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Reproductive Health Choices of Women. Date: March 24, 2006. Time: 10:30 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Carla T. Walls, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892. (301) 435–6898. wallsc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: February 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2228 Filed 3–8–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice BILLING CODE 4140–01–M VerDate Aug<31>2005 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Jkt 208001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; ZEB1 OSR–A M1 S 2006 Image Neural Activity. Date: April 3, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: David George, PhD, Director, Office of Scientific Review, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Blvd., Suite 920, Bethesda, MD 20892. 301–496–8633. georged1@mail.nih.gov Dated: February 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2230 Filed 3–8–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a National Science Advisory Board for Biosecurity (NSABB) meeting. Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding federal oversight of dual-use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/ or national security. The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend E:\FR\FM\09MRN1.SGM 09MRN1 Federal Register / Vol. 71, No. 46 / Thursday, March 9, 2006 / Notices should register online at https:// www.biosecurityboard.gov/meetings.asp or by calling The Hill Group (Contact: Jenny Chun) at 301–897–2789, ext. 115. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration. hsrobinson on PROD1PC70 with NOTICES Name of Committee: National Science Advisory Board for Biosecurity. Date: March 30, 2006. Time: 8 a.m. to 6:15 p.m. Agenda: Presentations and discussions regarding: (1) Criteria for identifying dual use research; (2) a code of conduct for the life sciences; (3) principles and tools for the responsible communication of dual use research; (4) international perspectives on dual use research; (5) synthetic genomics; (6) public comments; and (7) other business of the Board. Place: The National Institutes of Health, Building 31, 6C–Room 10, Bethesda, Maryland. Contact Person: Allison Chamberlain, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, MD 20892, (301) 402–3090. This meeting will also be Webcast. The draft meeting agenda and other information about NSABB, including information about access to the Webcast and pre-registration, will be available at https://www.biosecurityboard.gov/ meetings.asp. Any member of the public interested in presenting oral comments at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by March 17, 2005 and should be sent via email to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Allison Chamberlain. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: March 1, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2215 Filed 3–8–06; 8:45 am] BILLING CODE 4140–01–M 13:58 Mar 08, 2006 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, March 6, 2006, 8:30 a.m. to March 7, 2006, 1 p.m., One Washington Circle, One Washington Circle, NW., Washington, DC, 20037 which was published in the Federal Register on February 15, 2006, 71 FR 7985–7987. The meeting will be held one day only on March 6, 2006, from 8:30 a.m. to 6 p.m. The meeting location remains the same. The meeting is closed to the public. Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, March 22, 2006, 3 p.m. to March 22, 2006, 5 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on February 23, 2006, 71 FR 9362–9363. The starting time of the meeting on March 22, 2006 has been changed to 2 p.m. until adjournment. The meeting date and location remain the same. The meeting is closed to the public. Dated: March 1, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2213 Filed 3–8–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Dated: February 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2207 Filed 3–8–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, March 7, 2006, 11 a.m. to March 7, 2006, 12 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on February 23, 2006, 71 FR 9363–9367. The meeting will be held on March 21, 2006, from 4 p.m. to 5 p.m. The meeting location remains the same. The meeting is public. Dated: February 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–2208 Filed 3–8–06; 8:45am] BILLING CODE 4140–01–M VerDate Aug<31>2005 12209 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2004–19621] Dry Cargo Residue Discharges in the Great Lakes; Preparation of Environmental Impact Statement Coast Guard, DHS. Notice of intent; notice of availability; request for comments. AGENCY: ACTION: SUMMARY: The Coast Guard announces its intent to prepare an environmental impact statement (EIS) in connection with the development of proposed new regulations on the incidental discharge of dry cargo residue in the Great Lakes. Publication of this notice begins a public scoping process that will help determine the scope of issues to be addressed in the EIS and identify the significant environmental issues related to this EIS (40 CFR 1506.6). This notice also solicits public participation in the scoping process, and announces the availability of a study on current dry cargo residue discharge practices in the Great Lakes. DATES: Comments and related material must reach the Docket Management Facility on or before July 31, 2006. ADDRESSES: You may submit comments identified by Coast Guard docket number USCG–2004–19621 to the Docket Management Facility at the U.S. Department of Transportation. E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 71, Number 46 (Thursday, March 9, 2006)]
[Notices]
[Pages 12208-12209]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2215]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a National 
Science Advisory Board for Biosecurity (NSABB) meeting.
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
federal oversight of dual-use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public, however pre-registration is 
strongly recommended due to space limitations. Persons planning to 
attend

[[Page 12209]]

should register online at https://www.biosecurityboard.gov/meetings.asp 
or by calling The Hill Group (Contact: Jenny Chun) at 301-897-2789, 
ext. 115. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should indicate these requirements upon registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: March 30, 2006.
    Time: 8 a.m. to 6:15 p.m.
    Agenda: Presentations and discussions regarding: (1) Criteria 
for identifying dual use research; (2) a code of conduct for the 
life sciences; (3) principles and tools for the responsible 
communication of dual use research; (4) international perspectives 
on dual use research; (5) synthetic genomics; (6) public comments; 
and (7) other business of the Board.
    Place: The National Institutes of Health, Building 31, 6C-Room 
10, Bethesda, Maryland.
    Contact Person: Allison Chamberlain, NSABB Program Assistant, 
6705 Rockledge Drive, Bethesda, MD 20892, (301) 402-3090.

    This meeting will also be Webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the Webcast and pre-registration, will be available at https://
www.biosecurityboard.gov/meetings.asp.
    Any member of the public interested in presenting oral comments at 
the meeting may notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives of an organization may submit a letter of intent, a 
brief description of the organization represented and a short 
description of the oral presentation Only one representative of an 
organization may be allowed to present oral comments. Both printed and 
electronic copies are requested for the record. In addition, any 
interested person may file written comments with the committee. All 
written comments must be received by March 17, 2005 and should be sent 
via email to nsabb@od.nih.gov with ``NSABB Public Comment'' as the 
subject line or by regular mail to 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892, Attention Allison Chamberlain. The statement should 
include the name, address, telephone number and, when applicable, the 
business or professional affiliation of the interested person.

    Dated: March 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-2215 Filed 3-8-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.